Ranch Capital Advisors Inc. Bristol Myers Squibb CO Transaction History

Ranch Capital Advisors Inc.

  • $255 Million
  • Q3 2025

A detailed history of Ranch Capital Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ranch Capital Advisors Inc. holds 5,928 shares of BMY stock, worth $277,489. This represents 0.1% of its overall portfolio holdings.

Number of Shares
5,928
Previous 35,650 83.37%
Holding current value
$277,489
Previous $1.65 Million 83.82%
% of portfolio
0.1%
Previous 0.72%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$43.31 - $48.98 $1.29 Million - $1.46 Million
-29,722 Reduced 83.37%
5,928 $267,000
Q2 2025

Jul 31, 2025
BUY
$44.12 - $59.6 $66,665 - $90,055
1,511 Added 4.43%
35,650 $1.65 Million
Q1 2025

May 09, 2025
BUY
$53.9 - $63.11 $95,995 - $112,398
1,781 Added 5.5%
34,139 $2.08 Million
Q4 2024

Feb 07, 2025
BUY
$51.92 - $59.94 $60,331 - $69,650
1,162 Added 3.72%
32,358 $1.83 Million
Q3 2024

Nov 12, 2024
BUY
$39.66 - $51.75 $1.03 Million - $1.35 Million
26,013 Added 501.89%
31,196 $1.61 Million
Q2 2024

Aug 13, 2024
BUY
$40.25 - $52.99 $120 - $158
3 Added 0.06%
5,183 $215,000
Q1 2024

May 13, 2024
BUY
$47.98 - $54.4 $143 - $163
3 Added 0.06%
5,180 $280,000
Q4 2023

Feb 14, 2024
SELL
$48.48 - $57.85 $1,260 - $1,504
-26 Reduced 0.5%
5,177 $265,000
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $5,846 - $6,537
-101 Reduced 1.9%
5,203 $301,000
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $1,905 - $2,161
-29 Reduced 0.54%
5,304 $367,000
Q3 2022

Nov 10, 2022
BUY
$0.13 - $76.84 $0 - $76
1 Added 0.02%
5,333 $379,000
Q2 2022

Aug 10, 2022
BUY
$72.62 - $79.98 $145 - $159
2 Added 0.04%
5,332 $411,000
Q1 2022

May 12, 2022
BUY
$61.48 - $73.72 $122 - $147
2 Added 0.04%
5,330 $389,000
Q4 2021

Feb 08, 2022
BUY
$53.63 - $62.52 $53 - $62
1 Added 0.02%
5,328 $332,000
Q3 2021

Nov 15, 2021
BUY
$59.17 - $69.31 $118 - $138
2 Added 0.04%
5,327 $315,000
Q2 2021

Aug 16, 2021
SELL
$61.91 - $67.42 $5,819 - $6,337
-94 Reduced 1.73%
5,325 $355,000
Q1 2021

May 17, 2021
SELL
$59.34 - $66.74 $4,925 - $5,539
-83 Reduced 1.51%
5,419 $342,000
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $64,553 - $73,150
-1,118 Reduced 16.89%
5,502 $341,000
Q3 2020

Nov 16, 2020
SELL
$57.43 - $63.64 $647,695 - $717,731
-11,278 Reduced 63.01%
6,620 $399,000
Q2 2020

Aug 12, 2020
BUY
$54.82 - $64.09 $82,833 - $96,839
1,511 Added 9.22%
17,898 $1.11 Million
Q1 2020

May 12, 2020
BUY
$46.4 - $67.43 $538,657 - $782,794
11,609 Added 242.97%
16,387 $913,000
Q4 2019

Feb 13, 2020
SELL
$49.21 - $64.19 $1,623 - $2,118
-33 Reduced 0.69%
4,778 $307,000
Q3 2019

Nov 18, 2019
BUY
$42.77 - $50.71 $205,766 - $243,965
4,811 New
4,811 $244,000

Others Institutions Holding BMY

# of Institutions
2,680
Shares Held
1.58B
Call Options Held
28M
Put Options Held
28.4M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ranch Capital Advisors Inc. Portfolio

Follow Ranch Capital Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ranch Capital Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email